Kevin Kunzmann

A secukinumab researcher explains why the practice may become the "next stethoscope" of medicine.

New findings show a unique series of markers could indicate particular black SLE patient risks.

A dual-guest interview on the current leading research into advanced lung cancer screening and detection.

A real-world study shows the therapy was slightly more efficacious for biologic-naive PsA patients.

A systematic review suggests patients taking immunosuppressive therapy may not be at as heightened risk of infection as previously thought.

An interview with a study author on the promising findings, and the use of ultrasonography in assessing psoriatic arthritis treatment.

Children hospitalized from the condition face a 14-fold increased risk of MACE.

The world is suddenly fixed on the field's most promising agents for an unprecedented virus. It's created a unique situation for specialists to collaborate.

The common rheumatic drug was found in a cohort analysis to be linked to greater regional TB outbreaks.

Less than 2% of surveyed families with rheumatic-disease children had reported a COVID-19 case in the early pandemic—and even fewer had physician-confirmed symptoms.

A discussion on how the pandemic has burdened and, in some ways, bettered the very involved specialty.

New phase 1 data show the first-in-class oral therapy is not affected by the burden on metabolism via hepatic or renal disease.

New data presented at IDWeek showed more than half observed households with a COVID-19 case reported a secondary infection, oftentimes within 3 days.

New data show patients hospitalized with COVID-19 far more frequently suffer from cardiometabolic disease, yet face worse outcomes with COPD.

New cohort analysis shows patients with ulcerative colitis or Crohn's disease who have received invasive care may be affected long-term.

Two-thirds of all excess deaths this year have been directly driven by the pandemic, according to findings.

New findings from the Congo highlight risks both mothers and their children face in delivery.

Dr. Fauci gives perspective on the future presence of the virus, improving US pandemic preparedness, and the theological divisions which have plagued national response.

What the potential of monoclonal antibodies may be, and what's currently understood about serologic antibodies.

This edition from the 10 Year Plan features perspective from leadership at AAAAI and ACAAI, as well as survey results from allergists and pulmonologists.

This edition from the 10 Year Plan features perspective from leadership at ACC and ESC, as well as survey results from cardiologists.

Fauci shares his thoughts on leading COVID-19 vaccines, SARS-CoV-2 transmission, antibody research, and where the US went wrong in pandemic response.

Low annual donor use and high mortality rates could be correlatively improved with greater embrace of opportunities.

Interview results show patients can generally recall giving transfusion consent, but not information on the procedures benefits and risks.

New cohort analysis shows an over-reliance on therapy designed as an add-on for asthma control.

Twelve-year data shows patients without control of their asthma could suffer lung failure quickly if they aren't consistent in maintenance therapy.

New data shows nearly 40% of chronic lung disease patients from a Portuguese hospital died within 5 years of initiating respiratory rehabilitation.

Data shows certain personality traits are linked to a COPD patient's likelihood of active or sedentary behaviors.

The added indication makes the GSK single inhaler triple therapy the first of its kind approved for both asthma and COPD in the US.

The chief of thoracic surgery and surgical director of the Northwestern Medicine Lung Transplant Program discusses his unprecedented procedure during the pandemic.